ARCHIVES

FDA will return memento given to McClellan by NCI Director Andrew von Eschenbach.

This article is from The Cancer Letter archive.

Vol. 30 No. 06 | February 6, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Myers, Whang-Peng, Zink Leaving NCU; FDA Hires New Legislative Affairs Chief

February 18, 1994

In Brief: First CREG Announcement Due In Late April For In Vitro Carcinogen Test Improvements

March 21, 1975

CCOPs Get $1 Million More, Payline Raised To 228 Plus Exceptions

May 29, 1987

Committee Holds Up RFP For Frederick, Asks Six Month Delay

September 24, 1976

AACI Asks Funding Of Cancer Control Directors From Control Budget

February 11, 1983

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014